合計 50 件の最近のインサイダー取引記録が記録されています Sonnet BioTherapeutics Holdings, Inc. (SONN), 内訳は 36 件の買い および 12 件の売り. インサイダー買い総額は $250.99K インサイダー売り総額は $47.12K.
最近活動のある主要インサイダーには Mcandrew Stephen J, Kenney Richard T, Griffith Donald J.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — SONN
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-02-17 |
Mcandrew Stephen J |
Chief Business Officer |
不明 |
- |
- |
- |
446 |
| 2023-12-11 |
Kenney Richard T |
Chief Medical Officer |
RSU 付与(制限付株式) |
1,271 |
$0.00 |
$0.13 |
1,374 |
| 2023-12-11 |
Griffith Donald J. |
Director |
RSU 付与(制限付株式) |
317 |
$0.00 |
$0.03 |
375 |
| 2023-12-11 |
Mohan Pankaj |
Chairman, President and CEO |
RSU 付与(制限付株式) |
7,554 |
$0.00 |
$0.76 |
14,987 |
| 2023-12-11 |
Dyrness Albert D. |
Director |
RSU 付与(制限付株式) |
373 |
$0.00 |
$0.04 |
537 |
| 2023-12-11 |
Bhatt Nailesh |
Director |
RSU 付与(制限付株式) |
373 |
$0.00 |
$0.04 |
547 |
| 2023-12-11 |
Cini John K. |
Chief Scientific Officer |
RSU 付与(制限付株式) |
1,888 |
$0.00 |
$0.19 |
2,116 |
| 2023-12-11 |
Rao Raghu |
Director |
RSU 付与(制限付株式) |
373 |
$0.00 |
$0.04 |
2,356 |
| 2023-12-11 |
Cross John Harry Iii |
Chief Financial Officer |
RSU 返還(制限付株式) |
1,452 |
$0.00 |
$0.15 |
1,588 |
| 2023-12-11 |
Dexter Susan |
Chief Technical Officer |
RSU 付与(制限付株式) |
1,452 |
$0.00 |
$0.15 |
1,643 |
| 2023-12-11 |
Mcneill Lori |
Director |
RSU 付与(制限付株式) |
373 |
$0.00 |
$0.04 |
394 |
| 2023-10-27 |
Mohan Pankaj |
Chairman, President and CEO |
情報に基づく買い |
34,375 |
$1.60 |
$55K |
59,526 |
| 2023-10-27 |
Rao Raghu |
Director |
情報に基づく買い |
15,625 |
$1.60 |
$25K |
16,813 |
| 2023-08-07 |
Markey John |
10 Percent Owner |
処分 |
- |
- |
- |
186,430 |
| 2023-06-14 |
Dexter Susan |
Chief Technical Officer |
情報に基づく買い |
10,000 |
$0.70 |
$7K |
33,667 |
| 2023-05-30 |
Dyrness Albert D. |
Director |
情報に基づく買い |
23,255 |
$0.47 |
$10.88K |
28,962 |
| 2023-05-17 |
Bhatt Nailesh |
Director |
情報に基づく買い |
25,000 |
$0.23 |
$5.8K |
30,733 |
| 2023-05-15 |
Mohan Pankaj |
Chairman, President and CEO |
情報に基づく買い |
371,600 |
$0.22 |
$82.87K |
553,331 |
| 2023-03-15 |
Mohan Pankaj |
Chairman, President and CEO |
情報に基づく買い |
60,000 |
$0.59 |
$35.1K |
181,731 |
| 2023-02-06 |
Griffith Donald J. |
Director |
RSU 源泉徴収 |
497 |
$1.04 |
$518.37 |
10,301 |
| 2023-02-06 |
Cross John Harry Iii |
Chief Financial Officer |
RSU 源泉徴収 |
1,960 |
$1.06 |
$2.08K |
23,927 |
| 2023-01-07 |
Kenney Richard T |
Chief Medical Officer |
株式返還 |
14,627 |
$0.00 |
$1.46 |
3,571 |
| 2023-01-07 |
Mohan Pankaj |
Chairman, President and CEO |
株式返還 |
73,561 |
$0.00 |
$7.36 |
48,170 |
| 2023-01-07 |
Cini John K. |
Chief Scientific Officer |
株式返還 |
18,551 |
$0.00 |
$1.86 |
21,720 |
| 2023-01-07 |
Dexter Susan |
Chief Technical Officer |
株式返還 |
14,627 |
$0.00 |
$1.46 |
9,040 |
| 2022-12-14 |
Kenney Richard T |
Chief Medical Officer |
RSU 付与(制限付株式) |
14,627 |
- |
- |
64,627 |
| 2022-12-14 |
Mohan Pankaj |
Chairman, President and CEO |
RSU 付与(制限付株式) |
74,205 |
- |
- |
748,606 |
| 2022-12-14 |
Dyrness Albert D. |
Director |
RSU 付与(制限付株式) |
3,770 |
- |
- |
30,893 |
| 2022-12-14 |
Bhatt Nailesh |
Director |
RSU 付与(制限付株式) |
3,770 |
- |
- |
31,255 |
| 2022-12-14 |
Cini John K. |
Chief Scientific Officer |
RSU 付与(制限付株式) |
18,551 |
- |
- |
322,652 |
| 2022-12-14 |
Rao Raghu |
Director |
RSU 付与(制限付株式) |
3,770 |
- |
- |
26,140 |
| 2022-12-14 |
Cross John Harry Iii |
Chief Financial Officer |
RSU 付与(制限付株式) |
15,519 |
- |
- |
160,684 |
| 2022-12-14 |
Dexter Susan |
Chief Technical Officer |
RSU 付与(制限付株式) |
14,627 |
- |
- |
141,199 |
| 2022-12-14 |
Mcneill Lori |
Director |
RSU 付与(制限付株式) |
3,770 |
- |
- |
3,770 |
| 2022-12-09 |
Griffith Donald J. |
Director |
RSU 付与(制限付株式) |
3,214 |
$0.00 |
$0.32 |
10,798 |
| 2022-09-25 |
Mcneill Lori |
Director |
不明 |
- |
- |
- |
- |
| 2022-04-08 |
Griffith Donald J. |
Director |
RSU 源泉徴収 |
4,507 |
$0.37 |
$1.66K |
106,186 |
| 2021-12-15 |
Griffith Donald J. |
Director |
RSU 付与(制限付株式) |
15,000 |
$0.00 |
$1.50 |
110,693 |
| 2021-12-15 |
Mohan Pankaj |
Chairman, President and CEO |
RSU 付与(制限付株式) |
320,135 |
$0.00 |
$32.01 |
674,401 |
| 2021-12-15 |
Dyrness Albert D. |
Director |
RSU 付与(制限付株式) |
14,152 |
$0.00 |
$1.42 |
27,123 |
| 2021-12-15 |
Bhatt Nailesh |
Director |
RSU 付与(制限付株式) |
14,152 |
$0.00 |
$1.42 |
27,485 |
| 2021-12-15 |
Cini John K. |
Chief Scientific Officer |
RSU 付与(制限付株式) |
80,034 |
$0.00 |
$8.00 |
304,101 |
| 2021-12-15 |
Rao Raghu |
Director |
RSU 付与(制限付株式) |
14,152 |
$0.00 |
$1.42 |
22,370 |
| 2021-12-15 |
Cross John Harry Iii |
Chief Financial Officer |
RSU 付与(制限付株式) |
66,951 |
$0.00 |
$6.70 |
145,165 |
| 2021-12-15 |
Dexter Susan |
Chief Technical Officer |
RSU 付与(制限付株式) |
63,104 |
$0.00 |
$6.31 |
126,572 |
| 2021-06-09 |
Kenney Richard T |
Chief Medical Officer |
情報に基づく買い |
15,000 |
$1.54 |
$23.1K |
50,000 |
| 2021-06-09 |
Mohan Pankaj |
Chairman, President and CEO |
情報に基づく買い |
4,000 |
$1.55 |
$6.18K |
326,266 |
| 2021-05-25 |
Griffith Donald J. |
Director |
RSU 源泉徴収 |
4,235 |
$1.51 |
$6.39K |
95,693 |
| 2021-05-25 |
Cini John K. |
Chief Scientific Officer |
RSU 源泉徴収 |
14,004 |
$1.51 |
$21.15K |
224,067 |
| 2021-05-25 |
Dexter Susan |
Chief Technical Officer |
RSU 源泉徴収 |
10,145 |
$1.51 |
$15.32K |
63,468 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効